N+1 Singer shares its H2 2017 Review

In our H2 2017 review, we discuss the UK  economic and equity market environment in the second half of 2017, MiFIDII and how N+1 Singer is successfully adjusting its strategy to these challenges. 

2018 Extel survey

We at N+1 Singer are very proud of our Research output and we’ve listed below some of our achievements. We are grateful for the ongoing support of our institutional clients in internal and external surveys and

Read More
[Video] Pharmaceutical Services – Structural growth in a complex landscape

Please click on the video below to hear our analysts present the main themes of their latest Pharmaceutical Services sector report.    To receive the full sector note, email enquiry@n1singer.com

Read More
Theresa May’s Housing Speech and (overblown) Help to Buy concerns

The weekend saw a flurry of press articles describing the onset of Help to Buy interest payments as a “ticking time bomb”, rhetoric which we consider to be overblown. This was followed by yesterday’s housing speech

Read More
Alantra announces record net profit for 2017

N+1 Singer’s largest shareholder Alantra, the global investment banking and asset management firm, with offices across Europe, the US, Asia and Latin America,announced that it generated a record net profit of €30.2 million and achieved growth

Read More
“Synchronicity” – why investors need to take a view on Industrial stocks now!

At N+1 Singer we remain overweight the Industrials sector for now, but we think that the debate is finely balanced. On 13th February we published our first “Trend spotting” Strategy note of 2018 entitled “Synchronicity”. After

Read More
A further £250 million raised for the PRS REIT

The PRS REIT plc (affiliated with Sigma Capital Group plc), the first quoted Real Estate Investment Trust (“REIT”) to focus purely on the private rented sector (“PRS”), has today announced that it has successfully raised £250 million.

Read More

Transaction Highlights


Date: Feb 2018

Sector: Investment Funds

Type: Placing

£250.0 million

CVS Group

Date: Feb 2018

Sector: Life Sciences  

Type: Placing

£60.0 million

Stadium Group

Date: Feb 2018

Sector: Capital Goods  

Type: M&A advisory

£46.0 million

Communications about our events, transactions  and trends shaping industries.